BioSpace News Archive

Business

SeaSpine to Report Third Quarter 2019 Financial Results on October 29, 2019 Corresponding Conference Call and Webcast with Accompanying Slides to Discuss Results Available on SeaSpine Website at 4:30pm ET

SeaSpine Holdings Corporation announced that it will release third quarter 2019 financial results after the close of trading on Tuesday, October 29, 2019.

October 16, 2019
·
1 min read
Business

Amedisys Announces Third Quarter Earnings Release and Conference Call Date

Amedisys, Inc., announced that it will report results for the third quarter ended September 30, 2019, after the market closes on October 29, 2019.

October 16, 2019
·
1 min read
Business

TransMedics to Report Third Quarter 2019 Financial Results on November 6, 2019

The TransMedics management team will host a corresponding conference call beginning at 4:30 p.m. ET / 1:30 p.m. PT.

October 16, 2019
·
1 min read
Policy

ImmunoCellular Therapeutics Announces Settlement of Derivative Action Lawsuit

The Court approved the settlement amount of one hundred forty-five thousand dollars ($145,000.00) to be paid by ImmunoCellular’s insurer to Plaintiff’s Counsel, and for a Service Award of one thousand dollars ($1,000.00) to be paid to Plaintiff from the Fee and Expense Award.

October 16, 2019
·
2 min read
Drug Development

Regulus Therapeutics Presents Preclinical Data Identifying RGLS4326 as a Potential Disease-Modifying Treatment for Autosomal Dominant Polycystic Kidney Disease at OTS Annual Meeting

The poster presentation is available for download at http://regulusrx.com/publications.

October 16, 2019
·
3 min read
Drug Development

Kura Oncology Announces Upcoming Presentation at AACR-NCI-EORTC International Conference on Molecular Targets and Cancer Therapeutics

Preliminary results from a phase 2 trial of tipifarnib in squamous cell carcinomas (SCCs) with HRAS mutations

October 16, 2019
·
2 min read
Genetown

Charles River Laboratories Demonstrates Industry-Leading Research at Neuroscience 2019

The meeting, which brings together more than 30,000 researchers from 70 countries, will take place from October 19-23, in Chicago, Illinois.

October 16, 2019
·
4 min read
Genetown

Bicycle Therapeutics to Present New Translational Data for BT1718 and Preclinical Data for Other Bicycle® Toxin Conjugates at AACR-NCI-EORTC 2019

New translational data will be presented for BT1718, the Company’s lead Bicycle® Toxin Conjugate (BTC) product candidate, which define enrollment criteria for identifying expansion cohorts in the Phase IIa part of the ongoing Phase I/IIa trial with BT1718.

October 16, 2019
·
8 min read
Business

Mesoblast and Lonza Enter Into Agreement for Commercial Manufacture of Mesoblast’s Potential First United States Allogeneic Cell Therapy

Mesoblast and Lonza announced that they have entered into an agreement for commercial manufacture of Mesoblast’s lead allogeneic cell therapy product candidate, remestemcel-L for pediatric steroid-refractory acute graft versus host disease

October 16, 2019
·
6 min read
Business

Olympus Westborough Scheduled to Open in 2021

Olympus establishes hub of medical technology innovation, creating dynamic workplace for non-manufacturing employees

October 16, 2019
·
3 min read